Donald Arnold - McMaster Experts

Affiliations

Faculty of Health Sciences, McMaster University
Co-Director, McMaster Centre for Transfusion Research (MCTR), Faculty of Health Sciences
Associate Member, Health Research Methods, Evidence, and Impact, Faculty of Health Sciences
Professor, Medicine, Faculty of Health Sciences
Associate Member, Pathology & Molecular Medicine, Faculty of Health Sciences

Scholarly Activity in McMaster Experts

Co-author Network

Scholarly Activity
Research
Contact
View All

selected scholarly activity

chapters
- Management of immune‐mediated thrombocytopenia. 402-423. 2022
- Acquired Thrombocytopenia. 135-148. 2019
- Immune Thrombocytopenia. 127-144. 2019
- Chapter 131 Diseases of Platelet Number Immune Thrombocytopenia, Neonatal Alloimmune Thrombocytopenia, and Posttransfusion Purpura. 1944-1954. 2018
- Diseases of Platelet Number. 1944-1954. 2018
- Diseases of Platelet Number: Immune Thrombocytopenia, Neonatal Alloimmune Thrombocytopenia, and Posttransfusion Purpura. 1944-1954. 2017
- Management of immune‐mediated thrombocytopenia. 245-264. 2016
- The intensive care unit. European Respiratory Monograph. 85-89. 2013
- Red cell, platelet, and white cell antigens. 509-546. 2013
- Getting the Most Out of the Evidence for Transfusion Medicine. 505-515. 2013
- Acquired hemolytic anemia. 157-172. 2011
- Acquired hemolytic anemia. 157-172. 2011
- CHAPTER 10 Acquired hemolytic anemia. 157-172. 2011
- Management of Immune Thrombocytopenia. 344-375. 2009
- Thrombocytopenia and thrombocytosis. 983-1005. 2007
conferences
- Restrictive Versus Liberal Red Blood Cell Transfusion Strategies for Patients with Hematologic Malignancies Receiving Intensive Chemotherapy. Blood. 5573-5573. 2023
- P‐TS‐7 | An Evaluation of Plasma Transfusion Practices: A 10‐Year Retrospective Study. Transfusion. 258A-259A. 2023
- MRI, Efficacy, and Safety of Tolebrutinib in Highly Active Disease: 2-Year Data from Phase 2b Long-term Safety Study. European Journal of Neurology. 526-527. 2023
- Serum neurofilament light chain levels during natalizumab treatment with every-4-week and every-6-week dosing in NOVA. European Journal of Neurology. 528-529. 2023
- Illustrated State-of-the-Art Capsules of the ISTH 2023 Congress. Research and Practice in Thrombosis and Haemostasis. 100193-100193. 2023
- PATHOGENESIS OF PLATELET PROTHROMBOTIC STATES (HITT/VITT). American Journal of Hematology. E7-E8. 2023
- Challenges of containerization and robotization the telescope control system for large robotic telescope. Proceedings of SPIE - The International Society for Optical Engineering. 2022
- Challenges of the telescope control system for large robotic telescopes. Proceedings of SPIE - The International Society for Optical Engineering. 2020
- Transfusion Reactions Following the Implementation of Seven Day Platelets. Transfusion. 256A-256A. 2020
- A Regional Massive Hemorrhage Protocol: Designed with a Modified Delphi Technique to Obtain Consensus. Blood. 5792-5792. 2019
- Fostamatinib, a Spleen Tyrosine Kinase (SYK) Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (wAIHA): Final Results of the Phase 2, Multicenter, Open-Label Study. Blood. 3518-3518. 2019
- Identifying Patterns of Inappropriate Plasma Transfusion Practices Using a Novel Multicenter Electronic Data Audit: Over 80 Percent of Plasma Transfused Is Inappropriate. Blood. 3695-3695. 2019
- Impact of Iron Supplementation on Patient Outcomes in Women Undergoing Gynecological Procedures: Systematic Review and Meta-Analysis of Randomized Trials. Blood. 59-59. 2019
- Pathogenic Antibodies in Heparin-Induced Thrombocytopenia Specifically Target an Immunodominant Region on Platelet Factor 4. Blood. 219-219. 2019
- Perioperative Eltrombopag or Intravenous Immune Globulin for Patients with Immune Thrombocytopenia: A Multicenter Randomized Trial. Blood. 896-896. 2019
- Physicians' and Patients' Perspectives on Treatments in ITP - a Multi-Country Perspective: Results from the ITP World Impact Survey (I-WISh). Blood. 1097-1097. 2019
- Second-Line Therapy for Immune Thrombocytopenia: Real-World Experience. Blood. 2120-2120. 2019
- Small-Volume Tubes to Reduce Anemia and Transfusion (STRATUS): A Pragmatic Stepped Wedge Cluster Randomized Trial. Blood. 3685-3685. 2019
- Sex‐mismatched red blood cell transfusions and mortality: A systematic review and meta‐analysis. Vox Sanguinis. 505-516. 2019
- FOSTAMATINIB, A SPLEEN TYROSINE KINASE INHIBITOR, IS ACTIVE IN THE TREATMENT OF WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA: RESULTS OF THE SOAR PHASE 2, MULTICENTER, OPEN-LABEL STUDY. American Journal of Hematology. E34-E35. 2018
- IMPROVING LABORATORY TESTING FOR HEPARIN INDUCED THROMBOCYTOPENIA. American Journal of Hematology. E47-E48. 2018
- Autoantibodies to thrombopoietin and the thrombopoietin receptor in patients with immune thrombocytopenia. Blood. 234-241. 2018
- Anti-CD20 Monoclonal Antibody Therapy for Immune Modulation Across a Range of Autoimmune Diseases. Blood. 2017
- Emergency Management of Patients with Immune Thrombocytopenia and Severe Bleeding. Blood. 2017
- Long-Term Maintenance of Platelet Responses in Adult Patients with Persistent/Chronic Immune Thrombocytopenia Treated with Fostamatinib: 1-Year Efficacy and Safety Results. Blood. 2017
- Performance Characteristics of a Novel Platelet Viability Assay for Heparin-Induced Thrombocytopenia. Blood. 2017
- The Identification of the Amino Acids on Platelet Factor 4 That Bind Pathogenic Antibodies in Heparin-Induced Thrombocytopenia. Blood. 2017
- Analysis of Red Blood Cell Storage Duration and in-Hospital Mortality Using Time Dependent Exposure: Is the Oldest Blood Bad?. Transfusion. 33A-33A. 2017
- Megakaryocyte Apoptosis in the Bone Marrow of Patients with Immune Thrombocytopenia. Blood. 1379-1379. 2016
- The Effect of Platelet Transfusion on Death in the Intensive Care Unit. Blood. 3850-3850. 2016
- Developing a Data-driven Research Program: An Integrated Database Network Tool Driving Education and Research Forward. Transfusion. 237A-237A. 2016
- Informing Fresh Versus Old Red Cell Management (INFORM) Trial: A Large International Pragmatic Randomized Trial. Transfusion. 5A-5A. 2016
- Five-Year Outcomes of Halt-MS: High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation for Severe Relapsing-Remitting Multiple Sclerosis. Bone Marrow Transplantation. S61-S62. 2016
- Exploratory Analysis of a Blood Processing Method and In-hospital Mortality. Transfusion. 23A-23A. 2015
- Group O Red Blood Cells: Where is Universal donor blood Being Used?. Transfusion. 153A-154A. 2015
- Red Blood Cell Transfusion Antigen Matching Influence on Gestational Outcomes (AMIGO) Study. Transfusion. 25A-25A. 2015
- Higher or lower dose corticosteroids for primary immune thrombocytopenia: systematic review and meta-analysis. Journal of Thrombosis and Haemostasis. 40-40. 2015
- Interventions to reduce blood loss from laboratory testing in critically ill patients and impact on transfusion: a systematic review. Journal of Thrombosis and Haemostasis. 974-975. 2015
- A Phase II Study Evaluating the Efficacy of Rituximab in the Management of Patients with Relapsed or Refractory TTP. Blood. 4191-4191. 2014
- Difficulties in Establishing the Cause of Thrombocytopenia Among Ambulatory Patients Referred to Hematology: An Agreement Study. Blood. 3521-3521. 2014
- The Mcmaster ITP Registry: Assessing the Prevalence, Clinical and Laboratory Features of Immune Thrombocytopenia. Blood. 5008-5008. 2014
- lLow Level Platelet-Activating Antibodies in Patients Suspected of Having Heparin-Induced Thrombocytopenia but Testing Negative in the "Gold Standard" Functional Test. Blood. 2014
- Systematic Review and Meta-Analysis Of Rituximab For The Treatment Of Immune Thrombocytopenia In Adults. Blood. 1681-1681. 2013
- Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI). Transplantation and Cellular Therapy. S129-S129. 2013
- Persistent Impairments in Humoral and Cellular Immunity in Patients with Immune Thrombocytopenia Treated with Rituximab: A Sub-Study of a Randomized Controlled Trial. Blood. 2012
- Persistent Impairments in Humoral and Cellular Immunity in Patients with Immune Thrombocytopenia Treated with Rituximab: A Sub-Study of a Randomized Controlled Trial. Blood. 492-492. 2012
- Reporting Bleeding Outcomes in Adult and Pediatric Studies of Primary Immune Thrombocytopenia: A Systematic Review. Blood. 4281-4281. 2012
- Use of Intravenous Immune Globulin in Patients with Immune Thrombocytopenia Before and After Romiplostim: Real-World Experience. Blood. 4641-4641. 2012
- RINGO3: a multi-colour fast response polarimeter. Proceedings of SPIE - The International Society for Optical Engineering. 2012
- Prothrombin Complex Concentrates Reduce Blood Loss in Mice Rendered Coagulopathic by Warfarin but Not Dabigatran Etexilate. Transfusion. 56A-57A. 2012
- Quality of reporting of surveys in critical care journals. Critical Care Medicine. 441-449. 2012
- Bone Marrow Specimens From Patients with Immune Thrombocytopenia (ITP) Demonstrate Increased Megakaryocyte-Bound IgG and Increased T-Helper Cells. Blood. 972-972. 2011
- Identifying Drugs Implicated in Drug-Induced Immune Thrombocytopenia Using Levels of Evidence Applied to Laboratory Tests. Blood. 1421-1421. 2011
- Can We Do a 25,000 Patient Pragmatic Study to Address the Age of Blood and Mortality Controversy? A Pilot to Determine Feasibility. Transfusion. 193A-193A. 2011
- Quality Of Reporting Of Surveys In Critical Care Journals: A Methodologic Review. A104. INTENSIVE CARE UNIT ORGANIZATION, OUTCOMES, AND RESEARCH. a2390-a2390. 2011
- The Utility of Bone Marrow Examinations for the Diagnosis of Immune Thrombocytopenia. Blood. 1514-1514. 2010
- Understanding Treatment Preferences In Patients with Primary Immune Thrombocytopenia Contemplating Splenectomy: A Qualitative Study. Blood. 176-176. 2010
- A Multifaceted Strategy to Reduce Inappropriate Use of Fresh Frozen Plasma Transfusions in the Intensive Care Unit.. Blood. 575-575. 2009
- Adjudicating Bleeding Outcomes in a Large Thromboprophylaxis Trial in Critical Illness. Blood. 974-974. 2009
- Passive Transfer of Hepatitis B Core Antibody by Intravenous Immune Globulin-in Patients with Immune Thrombocytopenic Purpura. Blood. 955-955. 2009
- PSY38 ELICITING HEALTH STATE UTILITIES FOR IMMUNE (IDIOPATHIC) THROMBOCYTOPENIC PURPURA: RESULTS OF A GENERAL PUBLIC BASED TIME TRADE-OFF SURVEY. Value in Health. A382-A382. 2009
- A Mouse Model to Assess the Efficacy of Plasma Transfusion in the Prevention of Bleeding. Transfusion. 31A-31A. 2009
- The Development of a Bleeding Severity Measurement Scale (BSMS): A New Measurement Tool. Transfusion. 165A-165A. 2009
- A Canadian phase II study evaluating the efficacy of rituximab in the management of patients with relapsed/refractory thrombotic thrombocytopenic purpura. Kidney International, Supplement. S55-S58. 2009
- Autoantibodies in Patients with ITP Do Not Bind to Patient-Specific Epitopes on Platelet Glycoproteins. Blood. 1175-1175. 2008
- The Efficacy of H. pylori Eradication Therapy in H. pylori-Infected and Uninfected Patients with Immune Thrombocytopenic Purpura: A Systematic Review. Blood. 1170-1170. 2008
- Development of a mouse model for assessing the efficacy of plasma transfusion in reducing bleeding. Transfusion. 142A-142A. 2008
- Refractory thrombotic thrombocytopenic purpura in a patient with waldenstroms macroglobulinemia. Transfusion. 49A-50A. 2008
- A Generalization of the Blahut–Arimoto Algorithm to Finite-State Channels. IEEE Transactions on Information Theory. 1887-1918. 2008
- An individual platelet count set-point in ITP: A concept learned from patients with mild thrombocytopenia and a good response to IVIg or corticosteroids. Blood. 49B-49B. 2007
- Incidence of HPA-9b in Testing for Neonatal Alloimmune Thrombocytopenia.. Blood. 3214-3214. 2007
- Peripartum Management of Women with Suspected Hereditary Thrombocytopenia.. Blood. 3224-3224. 2007
- A systematic review and meta-analysis of platelets prepared from apheresis versus whole blood. Transfusion. 190A-190A. 2007
- An algorithm for "indeterminate" test results in the platelet serotonin release assay for heparin-induced thrombocytopenia (HIT).. Blood. 312A-312A. 2006
- Intravenous immunoglobulin as an adjunct to plasma exchange for the treatment of chronic thrombotic thrombocytopenic purpura: A case report. Transfusion. 44A-45A. 2006
- Simulation-Based Computation of Information Rates for Channels With Memory. IEEE Transactions on Information Theory. 3498-3508. 2006
- Rituximab for the treatment of adults with ITP: A systematic review. Blood. 361A-361A. 2005
- The HPA-15 (Gov) Platelet Alloantigen System: Allele Frequencies in the Canadian Population.. Blood. 2180-2180. 2005
- Proceedings of a Consensus Conference: Towards an Understanding of TRALI. Transfusion Medicine Reviews. 2-31. 2005
- Regular and irregular progressive edge-growth tanner graphs. IEEE Transactions on Information Theory. 386-398. 2005
- Platelet Transfusions in a Medical- Surgical Intensive Care Unit.. Blood. 3637-3637. 2004
- Survival of HIV infected individuals with hemophilia after 20 years: From the Canadian Hemophilia Registry.. Blood. 842A-843A. 2004
- The Effect of Prophylactic Administration of Myeloid Growth Factors Following Autologous Stem Cell Transplantation for Patients with Hematological Malignancies: A Systematic Review.. Blood. 2192-2192. 2004
- The Use of Aprotinin to Reduce Transfusion Requirements in Children Undergoing Cardiac Surgery: A Meta-Analysis.. Blood. 2718-2718. 2004
- A randomized crossover trial comparing in-vivo platelet recovery and survival of leukoreduced apheresis and whole blood derived platelets. Transfusion. 1A-1A. 2004
- On the data-processing inequality in the mismatch case. 2004 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY, PROCEEDINGS. 266-266. 2004
- Severe hypotension following transfusion of pre-storage leukoreduced red blood cells and acute normovolemic hemodilution whole blood. Transfusion. 112A-112A. 2003
- International Conferences on Abelian Group Theory: The First Forty Years. Rocky Mountain Journal of Mathematics. 1153-1160. 2002
- Cardiobacterium hominis endocarditis masquerading as very severe refractory immune thrombocytopenic purpura: Report of a case.. Blood. 83B-84B. 2002
- Pension guaranty programs: US and Canada. RECORD - SOCIETY OF ACTUARIES, VOL 20, NO 4A AND 4B. 1117-1132. 1995
- TORSION FREE ABELIAN QPI AND QPP GROUPS - PRELIMINARY-REPORT. Notices of the American Mathematical Society. A91-A91. 1976
journal articles
- Genetic predisposition to vaccine-induced immune thrombotic thrombocytopenia.. British Journal of Haematology. 2024
- Evaluating Diagnostic Algorithms for Heparin-Induced Thrombocytopenia using Two Combined Automated Rapid Immunoassays. Seminars in Vascular Medicine. 50:1123-1130. 2024
- The seasonal distribution of immune thrombotic thrombocytopenic purpura is influenced by geography: Epidemiologic findings from a multi‐center analysis of 719 disease episodes. American Journal of Hematology. 99:2063-2074. 2024
- Novel treatments for immune thrombocytopenia: targeting platelet autoantibodies. Expert Review of Hematology. 17:1-8. 2024
- Healthcare provider's perceptions of bleeding in patients with acute leukaemia undergoing induction chemotherapy: A qualitative study. Transfusion Medicine. 34:268-277. 2024
- The 2022 review of the 2019 American Society of Hematology guidelines on immune thrombocytopenia. Blood Advances. 8:3578-3582. 2024
- 2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19. Journal of Thrombosis and Haemostasis. 22:1779-1797. 2024
- Bleeding self‐assessments by patients with immune thrombocytopenia (ITP): An agreement study. American Journal of Hematology. 99:1184-1186. 2024
- Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support. Cochrane Database of Systematic Reviews. 2024:CD011305. 2024
- Evaluation of a diagnostic platelet aggregation test strategy for platelet rich plasma samples with low platelet counts. International Journal of Laboratory Hematology. 46:362-374. 2024
- Quality of life and cost‐effectiveness of convalescent plasma compared to standard care for hospitalized COVID‐19 patients in the CONCOR‐1 trial. Transfusion. 64:606-614. 2024
- Targeted ADAMTS-13 replacement therapy for thrombotic thrombocytopenic purpura. Journal of Thrombosis and Haemostasis. 22:896-904. 2024
- Hematology in the post-COVID era: spotlight on vaccine-induced immune thrombotic thrombocytopenia and a conceptual framework (the 4P’s) for anti-PF4 diseases. Expert Review of Hematology. 17:39-45. 2024
- Thrombopoietin Receptor Agonists and Other Second-Line Therapies for Immune Thrombocytopenia: A Narrative Review With a Focus on Drug Access in Canada. Clinical and Investigative Medicine. 47:13-22. 2024
- Treatment of critical bleeding events in patients with immune thrombocytopenia: a protocol for a systematic review and meta-analysis. Systematic Reviews. 13:21. 2024
- Evaluation of laboratory testing parameters for vaccine-induced immune thrombotic thrombocytopenia and their implications for diagnosis. Journal of Thrombosis and Haemostasis. 22:304-306. 2024
- Prevalence and significance of large granular lymphocytes in patients with immune thrombocytopenia. Platelets. 34:2144194. 2023
- An unsupervised learning approach to identify immunoglobulin utilization patterns using electronic health records. Transfusion. 63:2234-2247. 2023
- Small-Volume Blood Collection Tubes to Reduce Transfusions in Intensive Care. Journal of the American Medical Association (JAMA). 330:1872-1872. 2023
- Evaluation of Bleeding Self-Assessments By Patients with Immune Thrombocytopenia (ITP): An Agreement Study. Blood. 142:3958-3958. 2023
- The Lack of Tolerable Treatments Options That Can Induce Durable Responses without Fear of Relapse after Discontinuation Represents a Significant Unmet Need for Patients (Pts) with Immune Thrombocytopenia (ITP): Results from the ITP World Impact Survey (I-WISh) 2.0. Blood. 142:1212-1212. 2023
- Treatment of Critical Bleeding Events in Patients with Immune Thrombocytopenia: A Systematic Review. Blood. 142:7239-7239. 2023
- Data-driven fair resource allocation for novel emerging epidemics: a COVID-19 Convalescent Plasma case study. INFOR: Information Systems and Operational Research. 61:559-588. 2023
- Inhibition of neonatal Fc receptor as a treatment for immune thrombocytopenia. The Lancet. 402:1599-1601. 2023
- Antibodies against platelet factor 4 and the risk of cerebral venous sinus thrombosis in patients with vaccine-induced immune thrombotic thrombocytopenia. Journal of Thrombosis and Haemostasis. 21:2833-2843. 2023
- PB0343 Longitudinal Study on the Persistence of Anti-Platelet Factor 4 Antibodies in Vaccine-Induced Immune Thrombotic Thrombocytopenia after 14 Months. Research and Practice in Thrombosis and Haemostasis. 7:101485-101485. 2023
- PB0350 Prospective Study to Evaluate the Consolidated Performance of Two Automated Rapid Assays for the Diagnosis of Heparin-Induced Thrombocytopenia. Research and Practice in Thrombosis and Haemostasis. 7:101480-101480. 2023
- P‐BB‐8 | A Survey to Understand C1 Esterase Inhibitor Distribution Patterns and Use in Canada. Transfusion. 63:94A-95A. 2023
- P‐TS‐10 | An Unsupervised Learning Approach to Identify Immunoglobulin Utilization Patterns Using Electronic Health Records. Transfusion. 63:261A-262A. 2023
- Refractory immune thrombocytopenia in adults: Towards a new definition. British Journal of Haematology. 203:23-27. 2023
- Immunoglobulin utilization in Canada: a comparative analysis of provincial guidelines and a scoping review of the literature. Allergy, Asthma and Clinical Immunology. 19:85. 2023
- Investigation of anti-PF4 versus anti-PF4/heparin reactivity using fluid-phase enzyme immunoassay for 4 anti-PF4 disorders: classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, vaccine-induced immune thrombotic thrombocytopenia, and spontaneous HIT. Journal of Thrombosis and Haemostasis. 21:2268-2276. 2023
- Impact of iron supplementation on patient outcomes for women with abnormal uterine bleeding: a protocol for a systematic review and meta-analysis. Systematic Reviews. 12:121. 2023
- Huynh A, Arnold DM, Michael JV, et al. Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S. Blood Adv. 2023;7(2):246-250.. Blood Advances. 7:3113-3113. 2023
- Erratum. Transfusion. 63:1412-1412. 2023
- Adjudicating the Diagnosis of Immune Thrombocytopenia in a Clinical Research Study. TH Open. 07:e105-e109. 2023
- Adjudicating the Diagnosis of Immune Thrombocytopenia in a Clinical Research Study. TH Open. 07:e105-e109. 2023
- Adjudicating the Diagnosis of Immune Thrombocytopenia in a Clinical Research Study. TH Open. 7:e105-e109. 2023
- Adjudicating the Diagnosis of Immune Thrombocytopenia in a Clinical Research Study. TH Open. 7:e105-e109. 2023
- Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder. International Journal of Hematology. 117:341-348. 2023
- Lessons learned from the CONCOR‐1 trial. Transfusion Medicine. 33:21-25. 2023
- Proceedings of the immune thrombocytopenia summit: new concepts in mechanisms, diagnosis, and management. Research and Practice in Thrombosis and Haemostasis. 7:100097-100097. 2023
- Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S. Blood Advances. 7:246-250. 2023
- “Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia”: reply. Journal of Thrombosis and Haemostasis. 21:185-185. 2023
- A data‐informed system to manage scarce blood product allocation in a randomized controlled trial of convalescent plasma. Transfusion. 62:2525-2538. 2022
- Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia. Journal of Thrombosis and Haemostasis. 20:2988-2997. 2022
- Longitudinal Characteristics of Anti-Platelet Factor 4 Immunoglobulin G in Vaccine-Induced Immune Thrombotic Thrombocytopenia. Blood. 140:5640-5641. 2022
- Clinical and laboratory predictors of fetal and neonatal alloimmune thrombocytopenia. Transfusion. 62:2213-2222. 2022
- Continuing Medical Education. Transfusion. 62:2212-2212. 2022
- Longitudinal Characteristics of Anti-Platelet Factor 4 Immunoglobulin G in Vaccine-Induced Immune Thrombotic Thrombocytopenia. Blood. 140:5640-5641. 2022
- Plasma transfusion practices: A multicentre electronic audit. Vox Sanguinis. 117:1211-1219. 2022
- Polarimetry and photometry of gamma-ray bursts afterglows with RINGO3. Monthly Notices of the Royal Astronomical Society. 516:1584-1600. 2022
- Frequency and utility of bone marrow examination in relapsed/refractory immune thrombocytopenia. Journal of Thrombosis and Haemostasis. 20:2119-2126. 2022
- Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil. Vaccine. 40:4788-4795. 2022
- The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia. Blood Advances. 6:4228-4235. 2022
- Database‐driven research and big data analytic approaches in transfusion medicine. Transfusion. 62:1427-1434. 2022
- Transfusion thresholds in myelodysplastic syndrome—Helping patients live better. Transfusion. 62:1313-1314. 2022
- Heparin or nonheparin anticoagulants for VITT. Blood. 139:3358-3359. 2022
- Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open‐label study. American Journal of Hematology. 97:691-699. 2022
- SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia. Blood Advances. 6:2250-2253. 2022
- Post-cardiac surgery thrombotic thrombocytopenic purpura: presence of anti-ADAMTS13 autoantibodies at preoperative baseline. Platelets. 33:479-483. 2022
- Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT). Seminars in Hematology. 59:89-96. 2022
- Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. Blood Advances. 6:785-792. 2022
- Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial. Nature Medicine. 28:212-212. 2022
- From demand forecasting to inventory ordering decisions for red blood cells through integrating machine learning, statistical modeling, and inventory optimization. Transfusion. 62:87-99. 2022
- Reply to: Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19. Nature Medicine. 28:53-58. 2022
- T cell–mediated autoimmunity in immune thrombocytopenia. European Journal of Haematology. 108:18-27. 2022
- Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis. Frontiers in Cardiovascular Medicine. 9:1040196. 2022
- GRB 191016A: a highly collimated gamma-ray burst jet with magnetized energy injection. Monthly Notices of the Royal Astronomical Society. 509:5964-5973. 2021
- Lessons from vaccine-induced immune thrombotic thrombocytopenia. Nature Reviews Immunology. 21:753-755. 2021
- Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia. Advances in Therapy. 38:5791-5808. 2021
- Venous Thromboembolism and Mild Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. Thrombosis and Haemostasis. 121:1677-1680. 2021
- Perioperative Anemia Management in Women Undergoing Gynecologic Procedures: A 10 Year Multisite Study. Blood. 138:752-752. 2021
- Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19. Journal of the American Medical Association (JAMA). 326:1690-1690. 2021
- Platelet variability index: a measure of platelet count fluctuations in patients with immune thrombocytopenia. Blood Advances. 5:4256-4264. 2021
- All-trans retinoic acid for treating immune thrombocytopenia: new purpose for an old drug?. The Lancet Haematology. 8:e672-e673. 2021
- Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis. The BMJ. 374:n2231-n2231. 2021
- Extensive variability in platelet, bleeding, and QOL outcome measures in adult and pediatric ITP: Communication from the ISTH SSC subcommittee on platelet immunology. Journal of Thrombosis and Haemostasis. 19:2348-2354. 2021
- Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia. Nature. 596:565-569. 2021
- Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia. New England Journal of Medicine. 385:720-728. 2021
- Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology. Journal of Thrombosis and Haemostasis. 19:2082-2088. 2021
- Qualitative study to support the content validity of the immune thrombocytopenia (ITP) Life Quality Index (ILQI). British Journal of Haematology. 194:759-766. 2021
- The SSC platelet immunology register of VITT and VIITP: Toward standardization of laboratory and clinical parameters. Journal of Thrombosis and Haemostasis. 19:2094-2095. 2021
- Reconnaître, traiter et signaler les cas de thrombocytopénie immunitaire thrombotique induite par un vaccin. CANADIAN MEDICAL ASSOCIATION JOURNAL. 193:E1031-E1033. 2021
- Anemia-Induced Bleeding in Patients with Platelet Disorders. Transfusion Medicine Reviews. 35:22-28. 2021
- Performance characteristics of platelet autoantibody testing for the diagnosis of immune thrombocytopenia using strict clinical criteria. British Journal of Haematology. 194:439-443. 2021
- Recognizing, managing and reporting vaccine-induced immune thrombotic thrombocytopenia. CANADIAN MEDICAL ASSOCIATION JOURNAL. 193:E913-E915. 2021
- Recommendations for the clinical and laboratory diagnosis of VITT against COVID‐19: Communication from the ISTH SSC Subcommittee on Platelet Immunology. Journal of Thrombosis and Haemostasis. 19:1585-1588. 2021
- Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial. Trials. 22:323. 2021
- Platelet‐activating immune complexes identified in critically ill COVID‐19 patients suspected of heparin‐induced thrombocytopenia. Journal of Thrombosis and Haemostasis. 19:1342-1347. 2021
- Thrombocytopenia following Pfizer and Moderna SARS‐CoV‐2 vaccination. American Journal of Hematology. 96:534-537. 2021
- Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects. Viruses. 13:697-697. 2021
- A comparative study of platelet factor 4‐enhanced platelet activation assays for the diagnosis of heparin‐induced thrombocytopenia. Journal of Thrombosis and Haemostasis. 19:1096-1102. 2021
- Serotonin‐release assay‐positive but platelet factor 4‐dependent enzyme‐immunoassay negative: HIT or not HIT?. American Journal of Hematology. 96:320-329. 2021
- Immune thrombocytopenia (ITP) World Impact Survey (I‐WISh): Impact of ITP on health‐related quality of life. American Journal of Hematology. 96:199-207. 2021
- Immune thrombocytopenia (ITP) World Impact Survey (iWISh): Patient and physician perceptions of diagnosis, signs and symptoms, and treatment. American Journal of Hematology. 96:188-198. 2021
- Exploring the components of bleeding outcomes in transfusion trials for patients with hematologic malignancy. Transfusion. 61:286-293. 2021
- International survey on Helicobacter pylori testing in patients with immune thrombocytopenia: Communication of the platelet immunology scientific and standardization committee. Journal of Thrombosis and Haemostasis. 19:287-296. 2021
- Platelet Activating Immune Complexes Identified in COVID-19 Associated Coagulopathy 2020
- Extensive Variability in Platelet Count, Bleeding, and Quality of Life Outcome Measures in Adult and Pediatric Immune Thrombocytopenia: An Appraisal from a Critical Review of the Literature. Blood. 136:45-46. 2020
- Cluster‐randomized trials in transfusion medicine. Transfusion. 60:2470-2473. 2020
- The mega-importance of de novo lipogenesis in platelet production. Nature Metabolism. 2:999-1000. 2020
- The role of fluid-phase immune complexes in the pathogenesis of heparin-induced thrombocytopenia. Thrombosis Research. 194:135-141. 2020
- Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial. The Lancet Haematology. 7:e640-e648. 2020
- Platelet factor 4 inhibits ADAMTS13 activity and regulates the multimeric distribution of von Willebrand factor. British Journal of Haematology. 190:594-598. 2020
- Fetal/neonatal alloimmune thrombocytopenia: a systematic review of impact of HLA-DRB3*01:01 on fetal/neonatal outcome. Blood Advances. 4:3368-3377. 2020
- Platelet autoantibodies in the bone marrow of patients with immune thrombocytopenia. Blood Advances. 4:2962-2966. 2020
- Combination of two complementary automated rapid assays for diagnosis of heparin‐induced thrombocytopenia (HIT). Journal of Thrombosis and Haemostasis. 18:1435-1446. 2020
- Increased cytotoxic potential of CD8⁺T cells in immune thrombocytopenia. British Journal of Haematology. 188:e72-e76. 2020
- Serotonin‐release assay‐negative heparin‐induced thrombocytopenia. American Journal of Hematology. 95:38-47. 2020
- American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Advances. 3:3829-3866. 2019
- Premedication for the prevention of nonhemolytic transfusion reactions: a systematic review and meta‐analysis. Transfusion. 59:3609-3616. 2019
- Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Advances. 3:3780-3817. 2019
- A platelet viability assay (PVA) for the diagnosis of heparin-induced thrombocytopenia. Platelets. 30:1017-1021. 2019
- Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant. JAMA Internal Medicine. 179:1469-1469. 2019
- Postnatal intervention for the treatment of FNAIT: a systematic review. Journal of Perinatology. 39:1329-1339. 2019
- Corrigendum. Journal of Thrombosis and Haemostasis. 17:1578-1578. 2019
- First-Line Therapy for Immune Thrombocytopenia. Hamostaseologie. 39:259-265. 2019
- Timeline of heparin‐induced thrombocytopenia seroconversion in serial plasma samples tested using an automated latex immunoturbidimetric assay. International Journal of Laboratory Hematology. 41:493-502. 2019
- PF427 FOSTAMATINIB, A SPLEEN TYROSINE KINASE INHIBITOR, FOR THE TREATMENT OF WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA: INITIAL RESULTS OF THE OPEN‐LABEL EXTENSION PERIOD OF THE SOAR PHASE 2 STUDY. HemaSphere. 3:167-167. 2019
- PF703 LONG‐TERM FOSTAMATINIB TREATMENT OF ADULTS WITH IMMUNE THROMBOCYTOPENIA (ITP) DURING THE PHASE 3 CLINICAL TRIAL PROGRAM. HemaSphere. 3:306-306. 2019
- The association between platelet transfusions and mortality in patients with critical illness. Transfusion. 59:1962-1970. 2019
- Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence‐based practice, an international approach. British Journal of Haematology. 185:549-562. 2019
- Long‐term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program. American Journal of Hematology. 94:546-553. 2019
- The sensitivity and specificity of platelet autoantibody testing in immune thrombocytopenia: a systematic review and meta‐analysis of a diagnostic test. Journal of Thrombosis and Haemostasis. 17:787-794. 2019
- Peri-Operative Eltrombopag or Immune Globulin for Patients with Immune Thrombocytopaenia (The Bridging ITP Trial): Methods and Rationale. Thrombosis and Haemostasis. 119:500-507. 2019
- Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin‐induced thrombocytopenia. Journal of Thrombosis and Haemostasis. 17:389-399. 2019
- The association between blood donor sex and age and transfusion recipient mortality: an exploratory analysis. Transfusion. 59:482-491. 2019
- Maternal HPA‐1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review. Vox Sanguinis. 114:79-94. 2019
- Managing antithrombotic therapy in immune thrombocytopenia: development of the TH2 risk assessment score. Blood. 132:2684-2686. 2018
- Investigations for fetal and neonatal alloimmune thrombocytopenia: communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 16:2526-2529. 2018
- How do we diagnose immune thrombocytopenia in 2018?. Hematology. American Society of Hematology. Education Program. 2018:561-567. 2018
- Fluid-Phase Immune Complexes Can Assemble and Activate Platelets in Heparin-Induced Thrombocytopenia. Blood. 132:3746-3746. 2018
- Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin. Transfusion. 58:2729-2735. 2018
- Megakaryocyte apoptosis in immune thrombocytopenia. Platelets. 29:729-732. 2018
- High sensitivity and specificity of an automated IgG-specific chemiluminescence immunoassay for diagnosis of HIT. Blood. 132:1345-1349. 2018
- Erratum to: The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant who Need an Elective Surgery or Procedure: Design and Rationale. Thrombosis and Haemostasis. 118:1679-1680. 2018
- The potential role of a turbidimetric heart-type fatty acid-binding protein assay to aid in the interpretation of persistently elevated, non-changing, cardiac troponin I concentrations. Clinical Biochemistry. 58:53-59. 2018
- Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin‐induced thrombocytopenia. Journal of Thrombosis and Haemostasis. 16:1402-1412. 2018
- Cyclic thrombocytopenia with statistically significant neutrophil oscillations. Clinical Case Reports. 6:1347-1352. 2018
- Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials. American Journal of Hematology. 93:921-930. 2018
- Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay. Chest. 153:1396-1404. 2018
- The Use of Anticoagulation in Patients With Thrombocytopenia. Blood. 15. 2018
- Development of a high-yield expression and purification system for platelet factor 4. Platelets. 29:249-256. 2018
- Splenectomy for immune thrombocytopenia: down but not out. Blood. 131:1172-1182. 2018
- Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry. Blood Advances. 1:2414-2420. 2017
- Red blood cell storage and in-hospital mortality: a secondary analysis of the INFORM randomised controlled trial. The Lancet Haematology. 4:e544-e552. 2017
- A novel primary-specialist care collaborative demonstration project to improve the access and health care of medically complex patients. Chronic Illness. 13:151-170. 2017
- How we treat thrombotic thrombocytopenic purpura: Results of a Canadian TTP practice survey. Journal of Clinical Apheresis. 32:246-256. 2017
- The effect of rituximab on anti‐platelet autoantibody levels in patients with immune thrombocytopenia. British Journal of Haematology. 178:302-307. 2017
- Group O RBCs: where is universal donor blood being used. Vox Sanguinis. 112:336-342. 2017
- Performance characteristics of an automated latex immunoturbidimetric assay [HemosIL ® HIT-Ab (PF4-H) ] for the diagnosis of immune heparin-induced thrombocytopenia. Thrombosis Research. 153:108-117. 2017
- The unique immunological features of heparin‐induced thrombocytopenia. British Journal of Haematology. 177:198-207. 2017
- Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review. Blood. 129:1538-1547. 2017
- Blood Group Antigen Matching Influence on Gestational Outcomes (AMIGO) study. Transfusion. 57:525-532. 2017
- Thrombotic microangiopathies: a general approach to diagnosis and management. CANADIAN MEDICAL ASSOCIATION JOURNAL. 189:E153-E159. 2017
- Paroxysmal cold hemoglobinuria: a difficult diagnosis in adult patients. Transfusion. 57:137-143. 2017
- The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale. Thrombosis and Haemostasis. 117:2415-2424. 2017
- Autoantibodies to Thrombopoietin and the Thrombopoietin Receptor in Patients with Immune Thrombocytopenia. Blood. 128:2548-2548. 2016
- Effect of Short-Term vs. Long-Term Blood Storage on Mortality after Transfusion. New England Journal of Medicine. 375:1937-1945. 2016
- High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis. The Lancet Haematology. 3:e489-e496. 2016
- Transfusion‐related alloimmunization in children: epidemiology and effects of chemotherapy. Vox Sanguinis. 111:299-307. 2016
- Corticosteroids compared with intravenous immunoglobulin for the treatment of immune thrombocytopenia in pregnancy. Blood. 128:1329-1335. 2016
- EP21.08: Antenatal management of fetal neonatal alloimmune thrombocytopenia (FNAIT) and neonatal outcome according to the category of risk. Ultrasound in Obstetrics and Gynecology. 48:358-358. 2016
- Difficulties in establishing the diagnosis of immune thrombocytopenia: An agreement study. American Journal of Hematology. 91:E327-E329. 2016
- An evaluation of overall effectiveness and treatment satisfaction with intravenous immunoglobulin among patients with immune thrombocytopenia. Transfusion. 56:1739-1744. 2016
- Understanding intravenous iron ordering practices for inpatients and outpatients at a large academic institution. Transfusion Medicine Reviews. 30:147-147. 2016
- Producing megakaryocytes from a human peripheral blood source. Transfusion. 56:1066-1074. 2016
- Red blood cell processing methods and in-hospital mortality: a transfusion registry cohort study. The Lancet Haematology. 3:e246-e254. 2016
- Red blood cell processing methods and in-hospital mortality: a transfusion registry cohort study. The Lancet Haematology. 3:E246-E254. 2016
- Triplets with neonatal alloimmune thrombocytopenia due to antibodies against human platelet antigen 1a. Transfusion. 56:1166-1170. 2016
- Design and Implementation of a Competency-Based Transfusion Medicine Training Program in Canada. Transfusion Medicine Reviews. 30:30-36. 2016
- Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia. Transfusion. 56:73-79. 2016
- Platelet Transfusion Practices in the ICU: Data From a Large Transfusion Registry. Chest. 150:516-523. 2016
- Rationale and Design of the Informing Fresh versus Old Red Cell Management (INFORM) Trial: An International Pragmatic Randomized Trial. Transfusion Medicine Reviews. 30:25-29. 2016
- Bleeding complications in immune thrombocytopenia. Hematology. American Society of Hematology. Education Program. 2015:237-242. 2015
- Antibody binding to megakaryocytes in vivo in patients with immune thrombocytopenia. European Journal of Haematology. 95:532-537. 2015
- Distinguishing between anti–platelet factor 4/heparin antibodies that can and cannot cause heparin‐induced thrombocytopenia. Journal of Thrombosis and Haemostasis. 13:1900-1907. 2015
- Scholarly Success Among Internal Medicine Residents in Canada. Canadian Journal of General Internal Medicine. 10:33-37. 2015
- Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review: reply. Journal of Thrombosis and Haemostasis. 13:1522-1523. 2015
- A phase‐II sequential case‐series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab. British Journal of Haematology. 170:208-217. 2015
- Pitfalls in the diagnosis of heparin‐Induced thrombocytopenia: A 6‐year experience from a reference laboratory. American Journal of Hematology. 90:629-633. 2015
- The platelet serotonin‐release assay. American Journal of Hematology. 90:564-572. 2015
- Evaluation of the appropriateness of frozen plasma usage after introduction of prothrombin complex concentrates: a retrospective study. Vox Sanguinis. 108:274-280. 2015
- Recommendations for standardization of laboratory testing for drug‐induced immune thrombocytopenia: communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 13:676-678. 2015
- Risk infection to spare bleeding? The quandary of splenectomy for immune thrombocytopenia. American Journal of Hematology. 90:271-272. 2015
- Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. Journal of Thrombosis and Haemostasis. 13:457-464. 2015
- Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis. The Lancet Haematology. 2:e75-e81. 2015
- Plasma transfusion trials and tribulations. Transfusion. 55:14-16. 2015
- Low Level Platelet-Activating Antibodies in Patients Suspected of Having Heparin-Induced Thrombocytopenia but Testing Negative in the ”Gold Standard” Functional Test. Blood. 124:2757-2757. 2014
- The nature of the late achromatic bump in GRB 120326A. Astronomy and Astrophysics (A & A). 572:A55-A55. 2014
- Understanding why patients with immune thrombocytopenia are deeply divided on splenectomy. Health Expectations. 17:809-817. 2014
- γT‐S195A thrombin reduces the anticoagulant effects of dabigatran in vitro and in vivo. Journal of Thrombosis and Haemostasis. 12:1110-1115. 2014
- How to Succeed in Research During Medical Training: A Qualitative Study. Clinical and Investigative Medicine. 37:117-117. 2014
- Novel treatments for immune thrombocytopenia. Presse Medicale. 43:e87-e95. 2014
- Management of infants born with severe neonatal alloimmune thrombocytopenia: the role of platelet transfusions and intravenous immunoglobulin. Transfusion. 54:640-645. 2014
- Platelet transfusions for critically ill patients with thrombocytopenia. Blood. 123:1146-1151. 2014
- Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis. Intensive Care Medicine. 39:2135-2143. 2013
- The effects of rituximab on serum IgE and BAFF. Allergy, Asthma and Clinical Immunology. 9:39. 2013
- The Use Of Platelet Transfusions In The Intensive Care Unit and Impact On Platelet Count: A 30,000 Patient Registry Study. Blood. 122:1154-1154. 2013
- Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists. Transfusion. 53:2807-2812. 2013
- Thrombocytopenia in Critically Ill Patients Receiving Thromboprophylaxis. Chest. 144:1207-1215. 2013
- Utilization of frozen plasma in Ontario: a provincewide audit reveals a high rate of inappropriate transfusions. Transfusion. 53:2222-2229. 2013
- The effect of rituximab on vaccine responses in patients with immune thrombocytopenia. Blood. 122:1946-1953. 2013
- A platelet cover-up. Blood. 122:307-309. 2013
- Approach to the Diagnosis and Management of Drug-Induced Immune Thrombocytopenia. Transfusion Medicine Reviews. 27:137-145. 2013
- FcγRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia. Journal of Thrombosis and Haemostasis. 11:1146-1153. 2013
- Indecomposable (1,3)-Groups and a matrix problem. Czechoslovak Mathematical Journal. 63:307-355. 2013
- Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness. Thrombosis Research. 131:204-209. 2013
- Asthma Associated With Incontinentia Pigmenti and Fanconi Anemia. Chest. 143:856-858. 2013
- Nonheparin Anticoagulants for Heparin-Induced Thrombocytopenia. New England Journal of Medicine. 368:737-744. 2013
- A blinded study of bone marrow examinations in patients with primary immune thrombocytopenia. European Journal of Haematology. 90:121-126. 2013
- A systematic evaluation of laboratory testing for drug‐induced immune thrombocytopenia. Journal of Thrombosis and Haemostasis. 11:169-176. 2013
- Positioning new treatments in the management of immune thrombocytopenia. Pediatric Blood and Cancer. 60:S19-S22. 2013
- 118. Critical Care Medicine. 40:1-328. 2012
- 337. Critical Care Medicine. 40:1-328. 2012
- Leaving nothing to chance: how to randomize a clinical trial. Transfusion. 52:2513-2515. 2012
- Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura. Transfusion. 52:2517-2523. 2012
- A new tool to assess bleeding severity in patients with chemotherapy‐induced thrombocytopenia (CME). Transfusion. 52:2466-2474. 2012
- Continuing Medical Education Program in Transfusion. Transfusion. 52:2465-2465. 2012
- Platelet count or bleeding as the outcome in ITP trials?. American Journal of Hematology. 87:945-946. 2012
- Immune thrombocytopenia: Getting back to basics. American Journal of Hematology. 87:841-842. 2012
- Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate. Journal of Thrombosis and Haemostasis. 10:1830-1840. 2012
- A prospective study measuring the development of antibodies against platelet factor 4–heparin in healthy males after exposure to heparins. Journal of Thrombosis and Haemostasis. 10:1446-1449. 2012
- The effect of blood storage duration on in‐hospital mortality: a randomized controlled pilot feasibility trial. Transfusion. 52:1203-1212. 2012
- Recommendations for the implementation of platelet autoantibody testing in clinical trials of immune thrombocytopenia. Journal of Thrombosis and Haemostasis. 10:695-697. 2012
- A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia. Blood. 119:1356-1362. 2012
- In medical-surgical ICU patients, major bleeding is common but independent of heparin prophylaxis. Critical Care. 16:P435-P435. 2012
- Elicitation of utility scores in Canada for immune thrombocytopenia treated with romiplostim or watch and rescue. Journal of Medical Economics. 15:313-331. 2012
- A multifaceted strategy to reduce inappropriate use of frozen plasma transfusions in the intensive care unit. Journal of Critical Care. 26:636.e7-636.e13. 2011
- Bone Marrow Specimens From Patients with Immune Thrombocytopenia (ITP) Demonstrate Increased Megakaryocyte-Bound IgG and Increased T-Helper Cells. Blood. 118:2233-2233. 2011
- Identifying Drugs Implicated in Drug-Induced Immune Thrombocytopenia Using Levels of Evidence Applied to Laboratory Tests,. Blood. 118:3304-3304. 2011
- Adjudicating bleeding events in a platelet dose study: impact on outcome results and challenges. Transfusion. 51:2304-2310. 2011
- A Rational Approach to the Diagnosis and Management of Thrombocytopenia in the Hospitalized Patient. Seminars in Hematology. 48:251-258. 2011
- Consent in critical care trials: a survey of Canadian research ethics boards and critical care researchers. Journal of Critical Care. 26:533.e11-533.e22. 2011
- Piecing Together the Humoral and Cellular Mechanisms of Immune Thrombocytopenia. Seminars in Vascular Medicine. 37:631-639. 2011
- Survival of trauma patients after massive red blood cell transfusion using a high or low red blood cell to plasma transfusion ratio*. Critical Care Medicine. 39:1507-1513. 2011
- The association between platelet activation and FcγRIIa proteolysis. Journal of Thrombosis and Haemostasis. 9:885-887. 2011
- Bias in transfusion research: from study design to result reporting. Transfusion. 51:237-240. 2011
- The Frequency and Clinical Significance of Thrombocytopenia Complicating Critical Illness. Chest. 139:271-278. 2011
- Time to rethink clinically important outcomes in platelet transfusion trials. Transfusion. 51:430-434. 2011
- Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters. British Journal of Haematology. 152:52-60. 2011
- Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia. Transfusion. 50:2577-2581. 2010
- The Frequency and Clinical Significance of Thrombocytopenia Complicating Critical Illness: A Systematic Review. Blood. 116:4664-4664. 2010
- The Utility of Bone Marrow Examinations for the Diagnosis of Immune Thrombocytopenia.. Blood. 116:3691-3691. 2010
- Understanding Treatment Preferences In Patients with Primary Immune Thrombocytopenia Contemplating Splenectomy: A Qualitative Study. Blood. 116:392-392. 2010
- ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. Journal of Thrombosis and Haemostasis. 8:2063-2065. 2010
- A framework for resolving disagreement during end of life care in the critical care unit. Clinical and Investigative Medicine. 33:240-240. 2010
- Transfusion premedication to prevent acute transfusion reactions: a retrospective observational study to assess current practices. Transfusion. 50:1722-1730. 2010
- Preoperative risk assessment for bleeding and thromboembolism. Praxis. 99:609-611. 2010
- Präoperative Bewertung des Blutungs- und Thromboseembolierisikos. Praxis: a journal of writing and building. 99:609-612. 2010
- The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases. British Journal of Haematology. 149:3-13. 2010
- Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura. Blood. 115:29-31. 2010
- A Multifaceted Strategy to Reduce Inappropriate Use of Fresh Frozen Plasma Transfusions in the Intensive Care Unit.. Blood. 114:1412-1412. 2009
- Adjudicating Bleeding Outcomes in a Large Thromboprophylaxis Trial in Critical Illness.. Blood. 114:2471-2471. 2009
- Passive Transfer of Hepatitis B Core Antibody by Intravenous Immune Globulin in Patients with Immune Thrombocytopenic Purpura.. Blood. 114:2418-2418. 2009
- Spectral Analysis of Platelet Oscillations in Cyclic Thrombocytopenia.. Blood. 114:4459-4459. 2009
- Preoperative risk assessment for bleeding and thromboembolism. The BMJ. 339:b2299-b2299. 2009
- Bleeding and venous thromboembolism in the critically ill with emphasis on patients with renal insufficiency. Current Opinion in Pulmonary Medicine. 15:455-462. 2009
- ERRATA. Transfusion. 49:2012-2012. 2009
- Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses (vol 46, pg 1286, 2006). Transfusion. 49:2012-2012. 2009
- Comparison of direct and indirect methods of estimating health state utilities for resource allocation: review and empirical analysis. The BMJ. 339:b2688-b2688. 2009
- Pilot trials in transfusion medicine. Transfusion. 49:1293-1295. 2009
- New treatments for idiopathic thrombocytopenic purpura: rethinking old hypotheses. Expert Opinion on Investigational Drugs. 18:805-819. 2009
- Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review. Haematologica. 94:850-856. 2009
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 113:2386-2393. 2009
- The design and interpretation of pilot trials in clinical research in critical care. Critical Care Medicine. 37:S69-S74. 2009
- Autoantibodies in Patients with ITP Do Not Bind to Patient-Specific Epitopes on Platelet Glycoproteins.. Blood. 112:3427-3427. 2008
- The Efficacy of H. pylori Eradication Therapy in H. pylori-Infected and Uninfected Patients with Immune Thrombocytopenic Purpura: A Systematic Review.. Blood. 112:3413-3413. 2008
- Delayed‐onset HIT caused by low‐molecular‐weight heparin manifesting during fondaparinux prophylaxis. American Journal of Hematology. 83:876-878. 2008
- Diagnosis and Management of Neonatal Alloimmune Thrombocytopenia. Transfusion Medicine Reviews. 22:255-267. 2008
- An algorithm for resolving ‘indeterminate’ test results in the platelet serotonin release assay for investigation of heparin‐induced thrombocytopenia. Journal of Thrombosis and Haemostasis. 6:1595-1597. 2008
- “Spare-spleen-uximab” for chronic ITP. Blood. 112:925-926. 2008
- The use and abuse of surrogate endpoints in clinical research in transfusion medicine. Transfusion. 48:1547-1549. 2008
- Comparing the efficacy and safety of apheresis and whole blood–derived platelet transfusions: a systematic review. Transfusion. 48:1447-1458. 2008
- Does Helicobacter pylori Eradication Therapy Result in a Platelet Count Improvement in Adults with Immune Thrombocytopenic Purpura Regardless of H pylori Infection?. Hematology. American Society of Hematology. Education Program. 2008:31-32. 2008
- Evidence-Based Guidelines—An Introduction. Hematology. American Society of Hematology. Education Program. 2008:26-30. 2008
- SUBGROUPS OF FINITE DIRECT SUMS OF Z[1/n]. Houston Journal of Mathematics. 34:997-1007. 2008
- An Individual Platelet Count Set-Point in ITP: A Concept Learned from Patients with Mild Thrombocytopenia and a Good Response to IVIg or Corticosteroids.. Blood. 110:3926-3926. 2007
- Current Options for the Treatment of Idiopathic Thrombocytopenic Purpura. Seminars in Hematology. 44:S12-S23. 2007
- Representations of Finite Posets Over Discrete Valuation Rings. Communications in Algebra. 35:3128-3144. 2007
- Utilization of recombinant activated factor VII in southern Ontario in 85 patients with and without haemophilia. Haemophilia. 13:518-526. 2007
- In response. Annals of Internal Medicine. 147:281-282. 2007
- Rituximab for Patients with Idiopathic Thrombocytopenic Purpura. ACP journal club. 147:281-281. 2007
- Intravenous immunoglobulin as an adjunct to plasma exchange for the treatment of chronic thrombotic thrombocytopenic purpura. Vox Sanguinis. 93:173-175. 2007
- The science of systematic reviews. Transfusion. 47:1347-1349. 2007
- Testing for heparin‐induced thrombocytopenia: are we there yet?. Journal of Thrombosis and Haemostasis. 5:1371-1372. 2007
- Trends in the utilization and wastage of coagulation factor concentrates: the application of a regional tracking programme. Haemophilia. 13:271-278. 2007
- Passive Transfer of Peanut Hypersensitivity by Fresh Frozen Plasma. JAMA Internal Medicine. 167:853-853. 2007
- Systematic Review: Efficacy and Safety of Rituximab for Adults with Idiopathic Thrombocytopenic Purpura. ACP journal club. 146:25-25. 2007
- Bleeding during critical illness: A prospective cohort study using a new measurement tool. Clinical and Investigative Medicine. 30:93-93. 2007
- Synthesis and Biological Activity of a Focused Library of Mitogen‐activated Protein Kinase Phosphatase Inhibitors. Chemical Biology and Drug Design. 69:23-30. 2007
- Pure Submodules of Finite Direct Sums of Co-Purely Indecomposable Modules. Communications in Algebra. 35:355-369. 2006
- An Algorithm for “Indeterminate” Test Results in the Platelet Serotonin Release Assay for Heparin-Induced Thrombocytopenia (HIT).. Blood. 108:1048-1048. 2006
- Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses. Transfusion. 46:1286-1291. 2006
- Mortality rates and causes of death among all HIV-positive individuals with hemophilia in Canada over 21 years of follow-up. Blood. 108:460-464. 2006
- Representations of finite partially ordered sets over commutative artinian uniserial rings. Journal of Pure and Applied Algebra. 205:640-659. 2006
- Avoiding Transfusions in Children Undergoing Cardiac Surgery: A Meta-Analysis of Randomized Trials of Aprotinin. Anesthesia and Analgesia. 102:731-737. 2006
- In vivo recovery and survival of apheresis and whole blood‐derived platelets: a paired comparison in healthy volunteers. Transfusion. 46:257-264. 2006
- Mixed modules of finite torsion-free rank over a discrete valuation domain. Forum Mathematicum. 18:85-98. 2006
- Pi-balanced torsion-free modules over a discrete valuation domain. Journal of Algebra. 295:269-288. 2006
- Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Journal of Critical Care. 20:348-353. 2005
- Rituximab for the Treatment of Adults with ITP: A Systematic Review.. Blood. 106:1241-1241. 2005
- Heparin-Induced Thrombocytopenia: An Iceberg Rising. Mayo Clinic proceedings. 80:988-990. 2005
- Autologous peripheral blood progenitor cells are a potential source of parvovirus B19 infection. Transfusion. 45:394-398. 2005
- Endo-wild representation type and generic representations of finite posets. Pacific Journal of Mathematics. 219:1-26. 2005
- Survival of HIV Infected Individuals with Hemophilia after 20 Years: From the Canadian Hemophilia Registry.. Blood. 104:3085-3085. 2004
- Hypotensive transfusion reactions can occur with blood products that are leukoreduced before storage. Transfusion. 44:1361-1366. 2004
- Cardiobacterium hominis endocarditis associated with very severe thrombocytopenia and platelet autoantibodies. American Journal of Hematology. 76:373-377. 2004
- Torsion-free modules of finite rank over a discrete valuation ring. Journal of Algebra. 272:456-469. 2004
- Thrombocytopenia in medical–surgical ICU patients. Critical Care. 8:P125-P125. 2004
- Proceedings of the second Honolulu Conference on Abelian Groups and Modules. Rocky Mountain Journal of Mathematics. 32:1057-1059. 2002
- Direct sums of local torsion-free abelian groups. Proceedings of the American Mathematical Society. 130:1611-1617. 2002
- Finite rank Butler groups and torsion-free modules over a discrete valuation ring. Proceedings of the American Mathematical Society. 129:325-335. 2001
- Enterocutaneous Fistula Complicating Total Hip Arthroplasty. Clinical Orthopaedics and Related Research. 278:108???110-108???110. 1992
- Surgical management of chronic ulnar collateral ligament insufficiency of the thumb metacarpophalangeal joint.. Orthopaedic Review. 21:583-588. 1992
- Isomorphism invariants for abelian groups. Transactions of the American Mathematical Society. 330:711-724. 1992
- Field-independent representations of partially ordered sets. Forum Mathematicum. 4:349-357. 1992
- Almost Split Sequences for Dedekind-Like Rings. Journal of the London Mathematical Society. s2-43:225-235. 1991
- Duality and invariants for Butler groups. Pacific Journal of Mathematics. 148:1-10. 1991
- Logging calibration technology and facilities. IEEE Transactions on Nuclear Science. 35:844-846. 1988
- Natural gamma ray spectroscopy applied to borehole measurements. IEEE Transactions on Nuclear Science. 35:822-826. 1988
- Endomorphism rings of Butler groups. Journal of the Australian Mathematical Society. Series A. Pure mathematics and statistics. 42:322-329. 1987
- A Finite Global Azumaya Theorem in Additive Categories. Proceedings of the American Mathematical Society. 91:25-25. 1984
- Endomorphism rings and subgroups of finite rank torsion-free Abelian groups. Rocky Mountain Journal of Mathematics. 12:241-256. 1982
- FINITE RANK TORSION FREE ABELIAN-GROUPS AND RINGS. Lecture Notes in Mathematics. 931:R3-189. 1982
- Quasi-Pure Injective and Projective Torsion-Free Abelian Groups of Finite Rank. Proceedings of the London Mathematical Society. s3-38:532-544. 1979
- STRONGLY HOMOGENEOUS TORSION FREE ABELIAN-GROUPS OF FINITE RANK. Proceedings of the American Mathematical Society. 56:67-72. 1976
- P1589: PATIENT (PT) AND PHYSICIAN (MD) PERCEPTIONS OF THE BURDEN OF IMMUNE THROMBOCYTOPENIA (ITP) AND ITS MANAGEMENT: RESULTS FROM THE ITP WORLD IMPACT SURVEY (I-WISH) 2.0. HemaSphere. 7:e36093e7-e36093e7.
- Second-Line Therapy for Immune Thrombocytopenia: Real-World Experience in Canada. Canadian Journal of General Internal Medicine. 15:28-35.
- THE 4 M NEW ROBOTIC TELESCOPE PROJECT: AN UPDATED REPORT. Revista Mexicana de Astronomia y Astrofisica: Serie de Conferencias. 53:8-13.
preprints